Milestones expected in 1st half of this year (from presentation)
Ethics approval for BTX 1503 Phase Ia study = Done
DEA export licenses for cannabidiol to be used in clinical studies = Done
Study commencement (and data) for BTX 1503 Phase Ia safety study = June
Study data from PermetrexTM pipeline product = Any day
Sign licensing agreement for PermetrexTM technology with external strategic partner = Any day
New patent filings on other pipeline products = Any day
Exciting times
Ann: Botanix Receives Approval for Synthetic Cannabidiol Trial, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.010(6.06%) |
Mkt cap ! $303.9M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.3¢ | 15.5¢ | $2.753M | 17.44M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 81 | 3284118 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 302031 | 2 |
View Market Depth
| Last trade - 16.15pm 30/07/2025 (20 minute delay) ? |
| BOT (ASX) Chart |